JP2015506482A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015506482A5 JP2015506482A5 JP2014555777A JP2014555777A JP2015506482A5 JP 2015506482 A5 JP2015506482 A5 JP 2015506482A5 JP 2014555777 A JP2014555777 A JP 2014555777A JP 2014555777 A JP2014555777 A JP 2014555777A JP 2015506482 A5 JP2015506482 A5 JP 2015506482A5
- Authority
- JP
- Japan
- Prior art keywords
- blood
- inhibitor
- plasma
- instrument
- anticoagulant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 claims 20
- 239000008280 blood Substances 0.000 claims 20
- 239000003112 inhibitor Substances 0.000 claims 13
- 239000003146 anticoagulant agent Substances 0.000 claims 12
- 229940127219 anticoagulant drug Drugs 0.000 claims 12
- 229940127218 antiplatelet drug Drugs 0.000 claims 12
- 239000002904 solvent Substances 0.000 claims 8
- 238000000034 method Methods 0.000 claims 6
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 5
- 150000003180 prostaglandins Chemical class 0.000 claims 5
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 claims 4
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 claims 4
- 102000012479 Serine Proteases Human genes 0.000 claims 4
- 108010022999 Serine Proteases Proteins 0.000 claims 4
- 229960001123 epoprostenol Drugs 0.000 claims 4
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 claims 4
- 238000002955 isolation Methods 0.000 claims 4
- 239000002571 phosphodiesterase inhibitor Substances 0.000 claims 4
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 claims 4
- 229920000858 Cyclodextrin Polymers 0.000 claims 3
- 102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 claims 3
- 108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 claims 3
- 102000018389 Exopeptidases Human genes 0.000 claims 3
- 108010091443 Exopeptidases Proteins 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 3
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 3
- 229960002240 iloprost Drugs 0.000 claims 3
- HIFJCPQKFCZDDL-ACWOEMLNSA-N iloprost Chemical compound C1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)C(C)CC#CC)[C@H](O)C[C@@H]21 HIFJCPQKFCZDDL-ACWOEMLNSA-N 0.000 claims 3
- 229920001223 polyethylene glycol Polymers 0.000 claims 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 3
- 239000003001 serine protease inhibitor Substances 0.000 claims 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 102000035195 Peptidases Human genes 0.000 claims 2
- 108091005804 Peptidases Proteins 0.000 claims 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims 2
- 229940098773 bovine serum albumin Drugs 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- -1 cyprosten Chemical compound 0.000 claims 2
- 229960002768 dipyridamole Drugs 0.000 claims 2
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 claims 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 2
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 claims 2
- 230000000087 stabilizing effect Effects 0.000 claims 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims 2
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims 2
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 claims 1
- LGIPMFCHTFFLFR-PRYZLTTQSA-N 13,14-dehydro-15-cyclohexyl Carbaprostacyclin Chemical compound C([C@@H]1[C@H]2CC(/C[C@H]2C[C@H]1O)=C/CCCC(O)=O)#CC1(O)CCCCC1 LGIPMFCHTFFLFR-PRYZLTTQSA-N 0.000 claims 1
- IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 claims 1
- RJADQDXZYFCVHV-JQMWNLLFSA-N 5-[(2s,4r,5r,6ar)-5-hydroxy-4-[(e,3s)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydro-2h-cyclopenta[b]furan-2-yl]pentanoic acid Chemical compound O1[C@@H](CCCCC(O)=O)CC2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@H]21 RJADQDXZYFCVHV-JQMWNLLFSA-N 0.000 claims 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims 1
- XZFRIPGNUQRGPI-WBQKLGIQSA-N Carbaprostacyclin Chemical compound C1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 XZFRIPGNUQRGPI-WBQKLGIQSA-N 0.000 claims 1
- 102000005927 Cysteine Proteases Human genes 0.000 claims 1
- 108010005843 Cysteine Proteases Proteins 0.000 claims 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 1
- 229940122601 Esterase inhibitor Drugs 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 claims 1
- 101710090406 Meprin A subunit alpha Proteins 0.000 claims 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 229940122055 Serine protease inhibitor Drugs 0.000 claims 1
- 101710102218 Serine protease inhibitor Proteins 0.000 claims 1
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 1
- 229960005305 adenosine Drugs 0.000 claims 1
- 229960000711 alprostadil Drugs 0.000 claims 1
- 229960002890 beraprost Drugs 0.000 claims 1
- CTPOHARTNNSRSR-APJZLKAGSA-N beraprost Chemical compound O([C@H]1C[C@@H](O)[C@@H]([C@@H]21)/C=C/[C@@H](O)C(C)CC#CC)C1=C2C=CC=C1CCCC(O)=O CTPOHARTNNSRSR-APJZLKAGSA-N 0.000 claims 1
- 239000000090 biomarker Substances 0.000 claims 1
- 238000004820 blood count Methods 0.000 claims 1
- 229940001468 citrate Drugs 0.000 claims 1
- 239000000701 coagulant Substances 0.000 claims 1
- 239000013078 crystal Substances 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- 229960001259 diclofenac Drugs 0.000 claims 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 claims 1
- 229960002986 dinoprostone Drugs 0.000 claims 1
- QLBHNVFOQLIYTH-UHFFFAOYSA-L dipotassium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical group [K+].[K+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O QLBHNVFOQLIYTH-UHFFFAOYSA-L 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000002329 esterase inhibitor Substances 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 229960001680 ibuprofen Drugs 0.000 claims 1
- 229960000905 indomethacin Drugs 0.000 claims 1
- OJZYRQPMEIEQFC-UAWLTFRCSA-N limaprost Chemical compound CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O OJZYRQPMEIEQFC-UAWLTFRCSA-N 0.000 claims 1
- 229950009365 limaprost Drugs 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 229960001929 meloxicam Drugs 0.000 claims 1
- PZRHRDRVRGEVNW-UHFFFAOYSA-N milrinone Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1C PZRHRDRVRGEVNW-UHFFFAOYSA-N 0.000 claims 1
- 229960003574 milrinone Drugs 0.000 claims 1
- 229960002009 naproxen Drugs 0.000 claims 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 1
- 229960002702 piroxicam Drugs 0.000 claims 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 claims 1
- 239000004033 plastic Substances 0.000 claims 1
- 229920003023 plastic Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 claims 1
- 235000019833 protease Nutrition 0.000 claims 1
- 235000019419 proteases Nutrition 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 229960003676 tenidap Drugs 0.000 claims 1
- LXIKEPCNDFVJKC-QXMHVHEDSA-N tenidap Chemical compound C12=CC(Cl)=CC=C2N(C(=O)N)C(=O)\C1=C(/O)C1=CC=CS1 LXIKEPCNDFVJKC-QXMHVHEDSA-N 0.000 claims 1
- 229960002871 tenoxicam Drugs 0.000 claims 1
- WZWYJBNHTWCXIM-UHFFFAOYSA-N tenoxicam Chemical compound O=C1C=2SC=CC=2S(=O)(=O)N(C)C1=C(O)NC1=CC=CC=N1 WZWYJBNHTWCXIM-UHFFFAOYSA-N 0.000 claims 1
- 229960000278 theophylline Drugs 0.000 claims 1
- 230000009974 thixotropic effect Effects 0.000 claims 1
- 229950005371 zaprinast Drugs 0.000 claims 1
- REZGGXNDEMKIQB-UHFFFAOYSA-N zaprinast Chemical compound CCCOC1=CC=CC=C1C1=NC(=O)C2=NNNC2=N1 REZGGXNDEMKIQB-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261594152P | 2012-02-02 | 2012-02-02 | |
| US61/594,152 | 2012-02-02 | ||
| PCT/US2013/024416 WO2013116702A1 (en) | 2012-02-02 | 2013-02-01 | Sample collection devices with blood stabilizing agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015506482A JP2015506482A (ja) | 2015-03-02 |
| JP2015506482A5 true JP2015506482A5 (cg-RX-API-DMAC7.html) | 2016-03-10 |
Family
ID=48905892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014555777A Pending JP2015506482A (ja) | 2012-02-02 | 2013-02-01 | 血液安定剤を含んだサンプル採取器具 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20130209985A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2809289A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2015506482A (cg-RX-API-DMAC7.html) |
| CN (1) | CN104244902A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013214866A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014018970A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2862544A1 (cg-RX-API-DMAC7.html) |
| IN (1) | IN2014DN06981A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2014009256A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013116702A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011010633A (es) | 2009-04-09 | 2012-01-20 | Entegrion Inc | Productos sanguineos deshidratados por aspersion y metodos para elaborar los mismos. |
| US20110142885A1 (en) | 2009-09-16 | 2011-06-16 | Velico Medical, Inc. | Spray-dried human plasma |
| US20140083628A1 (en) | 2012-09-27 | 2014-03-27 | Velico Medical, Inc. | Spray drier assembly for automated spray drying |
| JP6382323B2 (ja) * | 2014-01-30 | 2018-08-29 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 室温での全血の安定化 |
| US9561184B2 (en) | 2014-09-19 | 2017-02-07 | Velico Medical, Inc. | Methods and systems for multi-stage drying of plasma |
| US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
| EP3334343B1 (en) | 2015-08-13 | 2022-10-19 | Takeda Pharmaceutical Company Limited | Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation |
| US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
| CN113751095B (zh) * | 2015-12-11 | 2024-01-09 | 巴布森诊断公司 | 用于从全血分离血清或血浆的样品容器和方法 |
| CN105372109A (zh) * | 2015-12-15 | 2016-03-02 | 苏州药明康德新药开发股份有限公司 | 添加稳定剂的生物基质的制备方法 |
| WO2018022991A1 (en) | 2016-07-29 | 2018-02-01 | Streck, Inc. | Suspension composition for hematology analysis control |
| WO2018090030A2 (en) | 2016-11-14 | 2018-05-17 | Siemens Healthcare Diagnostics Inc. | Sample preparation device |
| CN115990296B (zh) | 2017-09-22 | 2025-04-01 | 贝克顿·迪金森公司 | 用作导管封管液的4%柠檬酸三钠溶液 |
| ES2991437T3 (es) | 2017-10-19 | 2024-12-03 | Streck Llc | Composiciones para la regulación de la hemólisis y la coagulación y la estabilización de vesículas extracelulares |
| AU2018366901B2 (en) * | 2017-11-15 | 2022-02-03 | Radiometer Medical Aps | Heparin-based blood sampler without platelet activation |
| CN108311121B (zh) * | 2018-01-25 | 2021-05-14 | 健帆生物科技集团股份有限公司 | 一种血液灌流用吸附树脂及其制备方法和灌流器 |
| US12426815B2 (en) | 2018-04-27 | 2025-09-30 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Integrated device for self-collecting and automated pre-processing of biological fluids |
| JP7334468B2 (ja) * | 2018-05-29 | 2023-08-29 | 東ソー株式会社 | 血液試料保存剤 |
| JP7036670B2 (ja) * | 2018-05-31 | 2022-03-15 | アークレイ株式会社 | 血液中の稀少細胞検査、該検査ための血液処理方法及び採血管 |
| CA3133062C (en) | 2019-03-11 | 2024-01-23 | Siemens Healthcare Diagnostics Inc. | Syringe apparatus and methods |
| CA3140235A1 (en) * | 2019-05-14 | 2020-11-19 | Radiometer Medical Aps | Methods for determining blood gas or metabolic parameters |
| JP7402727B2 (ja) * | 2020-03-26 | 2023-12-21 | テルモ株式会社 | リン脂質含有物質安定化剤およびそれを含む体液検査キット |
| CN111521455A (zh) * | 2020-04-27 | 2020-08-11 | 中国科学院西北生态环境资源研究院 | 一种取样注射器的夹持单元及夹持方法 |
| CN112063513A (zh) * | 2020-09-21 | 2020-12-11 | 湖南洪江嵩云禽业有限公司 | 新型冰鲜禽肉储运新鲜度安全示警卡 |
| JPWO2022114031A1 (cg-RX-API-DMAC7.html) * | 2020-11-25 | 2022-06-02 | ||
| JP7728347B2 (ja) * | 2020-12-22 | 2025-08-22 | ラジオメーター・メディカル・アー・ペー・エス | 抗血小板剤および水溶性マトリックス材料を含有する血液サンプラー |
| US12050052B1 (en) | 2021-08-06 | 2024-07-30 | Babson Diagnostics, Inc. | Refrigerated carrier device for biological samples |
| EP4429738A4 (en) * | 2021-11-11 | 2025-06-25 | PRP Technologies, Inc. | SAMPLE COLLECTION DEVICE |
| EP4502599A1 (en) * | 2022-03-25 | 2025-02-05 | Sekisui Medical Co., Ltd. | Kit for isolating circulating tumor cells, container for isolating circulating tumor cells, and method for isolating circulating tumor cells |
| EP4505185A1 (en) | 2022-04-06 | 2025-02-12 | Babson Diagnostics, Inc. | Automated centrifuge loader |
| US11975274B2 (en) | 2022-09-15 | 2024-05-07 | Velico Medical, Inc. | Blood plasma product |
| US12246093B2 (en) | 2022-09-15 | 2025-03-11 | Velico Medical, Inc. | Methods for making spray dried plasma |
| US11998861B2 (en) | 2022-09-15 | 2024-06-04 | Velico Medical, Inc. | Usability of a disposable for a spray drying plasma system |
| US12246266B2 (en) | 2022-09-15 | 2025-03-11 | Velico Medical, Inc. | Disposable for a spray drying system |
| WO2024059770A1 (en) | 2022-09-15 | 2024-03-21 | Velico Medical, Inc. | Rapid spray drying system |
| US12083447B2 (en) | 2022-09-15 | 2024-09-10 | Velico Medical, Inc. | Alignment of a disposable for a spray drying plasma system |
| US11841189B1 (en) | 2022-09-15 | 2023-12-12 | Velico Medical, Inc. | Disposable for a spray drying system |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4104606C1 (cg-RX-API-DMAC7.html) * | 1991-02-12 | 1992-10-15 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | |
| FR2729823B1 (fr) * | 1995-01-31 | 2001-08-31 | Samama Meyer | Conservation de prelevements de sang, en particulier chez les malades traites par l'heparine |
| US6139878A (en) * | 1998-04-27 | 2000-10-31 | Aventis Behring, Llc | Method for preparing a diafiltered stabilized blood product |
| AU2001292894A1 (en) * | 2000-09-20 | 2002-04-02 | Surromed, Inc. | Method for monitoring resting and activated platelets in unfixed blood samples |
| KR100451485B1 (ko) * | 2002-03-28 | 2004-10-06 | 주식회사종근당 | 푸마질롤 유도체 또는 그 염의 포접 화합물, 및 이를포함하는 약제학적 조성물 |
| US7309468B2 (en) * | 2002-05-13 | 2007-12-18 | Becton, Dickinson And Company | Protease inhibitor sample collection system |
| AU2004263496B2 (en) * | 2003-08-05 | 2011-06-09 | Becton, Dickinson And Company | Device and methods for collection of a biological fluid sample and treatment of selected components |
| US20090123907A1 (en) * | 2004-07-22 | 2009-05-14 | Shanbrom Technologies, Llc | Lysine citrate for plasma protein and donor protection |
| US7700046B2 (en) * | 2004-09-14 | 2010-04-20 | Goldenberg Alec S | Controlled additive/reactant delivery system |
| DE102006020386A1 (de) * | 2006-04-28 | 2007-10-31 | Dade Behring Marburg Gmbh | Verfahren zur Bestimmung der Thrombozytenfunktion unter Flussbedingungen |
| DE102006045550A1 (de) * | 2006-09-25 | 2008-04-03 | Dade Behring Marburg Gmbh | Verfahren zur Herstellung von agglutionationsfähigen Thrombozytenfragmenten und deren Verwendung |
-
2013
- 2013-02-01 CN CN201380016577.5A patent/CN104244902A/zh active Pending
- 2013-02-01 CA CA2862544A patent/CA2862544A1/en not_active Abandoned
- 2013-02-01 MX MX2014009256A patent/MX2014009256A/es unknown
- 2013-02-01 US US13/757,080 patent/US20130209985A1/en not_active Abandoned
- 2013-02-01 BR BR112014018970A patent/BR112014018970A8/pt not_active IP Right Cessation
- 2013-02-01 IN IN6981DEN2014 patent/IN2014DN06981A/en unknown
- 2013-02-01 JP JP2014555777A patent/JP2015506482A/ja active Pending
- 2013-02-01 EP EP13743592.1A patent/EP2809289A4/en not_active Withdrawn
- 2013-02-01 WO PCT/US2013/024416 patent/WO2013116702A1/en not_active Ceased
- 2013-02-01 AU AU2013214866A patent/AU2013214866A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015506482A5 (cg-RX-API-DMAC7.html) | ||
| ES2527455T3 (es) | Diagnóstico clínico de fibrosis/cirrosis hepática usando biomarcadores de proteínas plasmáticas humanas poco abundantes | |
| TWD155414S (zh) | 醫療測試機械用碟片 | |
| BR112014018970A8 (pt) | Dispositivos de coleta de amostra com agentes de estabilização sanguínea | |
| EP3979923A4 (en) | ATRAUMATIC CLOSURE SYSTEM WITH CHAMBER FOR MEASUREMENT OF VESSEL PRESSURE CHANGES | |
| ATE434771T1 (de) | Triangulationssensor mit entfernungsbestimmung aus lichtfleckposition und -form | |
| WO2008021192A3 (en) | Markers of non-alcoholic fatty liver disease (nafld) and non-alcoholic steatohepatitis (nash) and methods of use thereof | |
| WO2013090631A3 (en) | Film thickness monitor | |
| JP2014513276A5 (cg-RX-API-DMAC7.html) | ||
| MA31372B1 (fr) | Cartouche de sorbant à bords biseautés. | |
| CY1118253T1 (el) | Υλικο βαθμονομησης για ανοσοποσοτικους προσδιορισμους | |
| WO2006113831A3 (en) | Method of measuring bleeding volume | |
| AR055764A1 (es) | Monitoreo de procedimiento de limpieza | |
| JP2009204612A5 (cg-RX-API-DMAC7.html) | ||
| EP3856710A4 (en) | COMPOSITIONS AND METHODS TO DETERMINE THE PRESENCE OF ACTIVE WEUKOCYTE CELLS USING AN ELECTROCHEMICAL ASSAY | |
| RU2007111434A (ru) | Способ определения количества жидкости, перемещаемой поверхностно-активным веществом | |
| CN103308606B (zh) | 横波聚焦冲水超声波探头 | |
| EP3977137A4 (en) | DETECTION OF ANALYTES THROUGH NANOPORES WITHOUT THE USE OF ELECTRODES | |
| BR102012017193A2 (pt) | Sensor de líquido | |
| RU2005137642A (ru) | Способ неинвазивного мониторинга фиброза печени у больных хроническим гепатитом с | |
| CN105043309A (zh) | 一种测模具内孔尺寸的方法 | |
| ES2545807B1 (es) | Procedimiento de determinación de la relación agua / mortero utilizada en la elaboración de morteros monocapa | |
| CN215191560U (zh) | 一种伤口测量卡尺 | |
| CN204495601U (zh) | 一种粘性样品取样匙 | |
| CL2013000443A1 (es) | Metodo para el diagnostico de fiebre q en un sujeto que comprende contactar la muestra del sujeto con una fuente de antigeno de coxiella burnetii y determinar el nivel de expresion de una citoquina proinflamatoria; y dispositivo de ensayo utilizado. |